SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Dermatology Practice Consolidation Fueled by Private Equity Investment
0 references·14 citing·28 second hop
Dermatology Practice Consolidation Fueled by Private Equity Investment (2017)Dermatology Practice Consolidation Fueled…Workforce Composition In Private Equity–Acquired Versus Non–Private Equity–Acquired Physician Practices (2023)Workforce Composition In Priv…Evaluating trends in private equity ownership and impacts on health outcomes, costs, and quality: systematic review (2023)Evaluating trends in private …Private equity and its effect on patients: a window into the future (2022)Private equity and its effect…Private Equity Investments In Health Care: An Overview Of Hospital And Health System Leveraged Buyouts, 2003–17 (2021)Private Equity Investments In…Private Equity In Dermatology: Effect On Price, Utilization, And Spending (2021)Private Equity In Dermatology…Private Equity and Physician Medical Practices — Navigating a Changing Ecosystem (2021)Private Equity and Physician …Insurance Acceptance, Appointment Wait Time, and Dermatologist Access Across Practice Types in the US (2021)Insurance Acceptance, Appoint…The Growth Of Private Equity Investment In Health Care: Perspectives From Ophthalmology (2020)The Growth Of Private Equity …Private Equity in Ophthalmology and Optometry (2020)Private Equity in Ophthalmolo…Changes in Hospital Income, Use, and Quality Associated With Private Equity Acquisition (2020)Changes in Hospital Income, U…The Emergence of Private Equity in Ophthalmology (2019)The Emergence of Private Equi…Private Equity Investment in Behavioral Health Treatment Centers (2019)Private Equity Investment in …Private Equity Acquisition of Physician Practices (2019)Private Equity Acquisition of…Future considerations for clinical dermatology in the setting of 21st century American policy reform: Corporatization and the rise of private equity in dermatology (2018)Future considerations for cli…The New Medical-Industrial Complex (1980)Creaming, skimping and dumping: provider competition on the intensive and extensive margins (1998)Creditor Control and Conflict in Chapter 11 (2009)Hospitals, Market Share, and Consolidation (2013)Potential Implications of Private Equity Investments in Health Care Delivery (2019)Trends in Private Equity Acquisition of Dermatology Practices in the United States (2019)Life cycle of private equity investments in physician practices: an overview of private equity exits (2024)How Do Hospitals Respond to Price Changes? (2005)Extreme Markup: The Fifty US Hospitals With The Highest Charge-To-Cost Ratios (2015)Changes in Quality of Care after Hospital Mergers and Acquisitions (2020)Medicare, medicaid, and access to dermatologists: The effect of patient insurance on appointment access and wait times (2003)Even patients with changing moles face long dermatology appointment wait-times: A study of simulated patient calls to dermatologists (2006)Barriers to healthcare access in pediatric dermatology: A systematic review (2021)How Dermatologists Can Address the Structural and Social Determinants of Health—From Awareness to Action (2022)Do hospital mergers reduce costs? (2017)Radical Reorientation of the US Health Care System Around Relationships (2022)Hospital-Physician Consolidation Accelerated In The Past Decade In Cardiology, Oncology (2018)Stealth Consolidation: Evidence from an Amendment to the Hart-Scott-Rodino Act (2019)Association of Private Equity Acquisition of Physician Practices With Changes in Health Care Spending and Utilization (2022)Private equity and healthcare firm behavior: Evidence from ambulatory surgery centers (2023)Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation (2015)ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions (2016)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)Changes in Hospital Adverse Events and Patient Outcomes Associated With Private Equity Acquisition (2023)The effect of health-care privatisation on the quality of care (2024)The Financialization of Health in the United States (2024)The High Stakes of Outsourcing in Health Care (2021)Physician Perspectives on Private Equity Investment in Health Care (2024)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2023Evaluating trends in private equity ownership and impacts on health outcomes, costs, and quality: systematic review206 cited
  • 2020Changes in Hospital Income, Use, and Quality Associated With Private Equity Acquisition138 cited
  • 2021Insurance Acceptance, Appointment Wait Time, and Dermatologist Access Across Practice Types in the US115 cited
  • 2021Private Equity Investments In Health Care: An Overview Of Hospital And Health System Leveraged Buyouts, 2003–17105 cited
  • 2021Private Equity In Dermatology: Effect On Price, Utilization, And Spending102 cited
  • 2018Future considerations for clinical dermatology in the setting of 21st century American policy reform: Corporatization and the rise of private equity in dermatology75 cited
  • 2023Workforce Composition In Private Equity–Acquired Versus Non–Private Equity–Acquired Physician Practices73 cited
  • 2020Private Equity in Ophthalmology and Optometry64 cited
  • 2020The Growth Of Private Equity Investment In Health Care: Perspectives From Ophthalmology62 cited
  • 2021Private Equity and Physician Medical Practices — Navigating a Changing Ecosystem58 cited
  • 2019Private Equity Acquisition of Physician Practices52 cited
  • 2019The Emergence of Private Equity in Ophthalmology38 cited
  • 2019Private Equity Investment in Behavioral Health Treatment Centers

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

31 cited
  • 2022Private equity and its effect on patients: a window into the future28 cited